AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...

Full description

Saved in:
Bibliographic Details
Main Authors: Hrstka, Roman, Brychtova, Veronika, Fabian, Pavel, Vojtesek, Borivoj, Svoboda, Marek
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2013
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/
https://ncbi.nlm.nih.gov/pubmed/24167368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items